These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34516577)

  • 21. Macrophage Migration Inhibitory Factor (MIF) and D-Dopachrome Tautomerase (DDT): Pathways to Tumorigenesis and Therapeutic Opportunities.
    Valdez CN; Sánchez-Zuno GA; Bucala R; Tran TT
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysregulated D-dopachrome tautomerase, a hypoxia-inducible factor-dependent gene, cooperates with macrophage migration inhibitory factor in renal tumorigenesis.
    Pasupuleti V; Du W; Gupta Y; Yeh IJ; Montano M; Magi-Galuzzi C; Welford SM
    J Biol Chem; 2014 Feb; 289(6):3713-23. PubMed ID: 24356968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MNK Inhibition Disrupts Mesenchymal Glioma Stem Cells and Prolongs Survival in a Mouse Model of Glioblastoma.
    Bell JB; Eckerdt FD; Alley K; Magnusson LP; Hussain H; Bi Y; Arslan AD; Clymer J; Alvarez AA; Goldman S; Cheng SY; Nakano I; Horbinski C; Davuluri RV; James CD; Platanias LC
    Mol Cancer Res; 2016 Oct; 14(10):984-993. PubMed ID: 27364770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrophage migration inhibitory factor (MIF) is rendered enzymatically inactive by myeloperoxidase-derived oxidants but retains its immunomodulatory function.
    Dickerhof N; Schindler L; Bernhagen J; Kettle AJ; Hampton MB
    Free Radic Biol Med; 2015 Dec; 89():498-511. PubMed ID: 26453918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of structurally distinct, isoform-selective phosphoinositide 3'-kinase inhibitors in combination with radiation in the treatment of glioblastoma.
    Chen JS; Zhou LJ; Entin-Meer M; Yang X; Donker M; Knight ZA; Weiss W; Shokat KM; Haas-Kogan D; Stokoe D
    Mol Cancer Ther; 2008 Apr; 7(4):841-50. PubMed ID: 18413797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion.
    Otvos B; Silver DJ; Mulkearns-Hubert EE; Alvarado AG; Turaga SM; Sorensen MD; Rayman P; Flavahan WA; Hale JS; Stoltz K; Sinyuk M; Wu Q; Jarrar A; Kim SH; Fox PL; Nakano I; Rich JN; Ransohoff RM; Finke J; Kristensen BW; Vogelbaum MA; Lathia JD
    Stem Cells; 2016 Aug; 34(8):2026-39. PubMed ID: 27145382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
    Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
    Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tanshinone IIA inhibits the growth, attenuates the stemness and induces the apoptosis of human glioma stem cells.
    Yang L; Guo H; Dong L; Wang L; Liu C; Wang X
    Oncol Rep; 2014 Sep; 32(3):1303-11. PubMed ID: 24970314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Up-regulation of macrophage migration inhibitory factor gene and protein expression in glial tumor cells during hypoxic and hypoglycemic stress indicates a critical role for angiogenesis in glioblastoma multiforme.
    Bacher M; Schrader J; Thompson N; Kuschela K; Gemsa D; Waeber G; Schlegel J
    Am J Pathol; 2003 Jan; 162(1):11-7. PubMed ID: 12507885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma.
    Guo G; Sun Y; Hong R; Xiong J; Lu Y; Liu Y; Lu J; Zhang Z; Guo C; Nan Y; Huang Q
    Clin Transl Oncol; 2020 Aug; 22(8):1252-1262. PubMed ID: 31865606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repurposing phenformin for the targeting of glioma stem cells and the treatment of glioblastoma.
    Jiang W; Finniss S; Cazacu S; Xiang C; Brodie Z; Mikkelsen T; Poisson L; Shackelford DB; Brodie C
    Oncotarget; 2016 Aug; 7(35):56456-56470. PubMed ID: 27486821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CXCR4 antagonism sensitizes cancer cells to novel indole-based MDM2/4 inhibitors in glioblastoma multiforme.
    Daniele S; La Pietra V; Piccarducci R; Pietrobono D; Cavallini C; D'Amore VM; Cerofolini L; Giuntini S; Russomanno P; Puxeddu M; Nalli M; Pedrini M; Fragai M; Luchinat C; Novellino E; Taliani S; La Regina G; Silvestri R; Martini C; Marinelli L
    Eur J Pharmacol; 2021 Apr; 897():173936. PubMed ID: 33581134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting distinct tautomerase sites of D-DT and MIF with a single molecule for inhibition of neutrophil lung recruitment.
    Rajasekaran D; Zierow S; Syed M; Bucala R; Bhandari V; Lolis EJ
    FASEB J; 2014 Nov; 28(11):4961-71. PubMed ID: 25016026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrophage Migration Inhibitory Factor (MIF) and Its Homologue d-Dopachrome Tautomerase (DDT) Inversely Correlate with Inflammation in Discoid Lupus Erythematosus.
    Caltabiano R; De Pasquale R; Piombino E; Campo G; Nicoletti F; Cavalli E; Mangano K; Fagone P
    Molecules; 2021 Jan; 26(1):. PubMed ID: 33401503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ionizing radiation augments glioma tropism of mesenchymal stem cells.
    Thomas JG; Parker Kerrigan BC; Hossain A; Gumin J; Shinojima N; Nwajei F; Ezhilarasan R; Love P; Sulman EP; Lang FF
    J Neurosurg; 2018 Jan; 128(1):287-295. PubMed ID: 28362237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of MEK162 as a Radiosensitizer for the Treatment of Glioblastoma.
    Narayan RS; Gasol A; Slangen PLG; Cornelissen FMG; Lagerweij T; Veldman HYYE; Dik R; van den Berg J; Slotman BJ; Würdinger T; Haas-Kogan DA; Stalpers LJA; Baumert BG; Westerman BA; Theys J; Sminia P
    Mol Cancer Ther; 2018 Feb; 17(2):347-354. PubMed ID: 28958992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Basic Gene Expression Characteristics of Glioma Stem Cells and Human Glioblastoma.
    Sakamoto D; Takagi T; Fujita M; Omura S; Yoshida Y; Iida T; Yoshimura S
    Anticancer Res; 2019 Feb; 39(2):597-607. PubMed ID: 30711935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sorafenib inhibits cell growth but fails to enhance radio- and chemosensitivity of glioblastoma cell lines.
    Riedel M; Struve N; Müller-Goebel J; Köcher S; Petersen C; Dikomey E; Rothkamm K; Kriegs M
    Oncotarget; 2016 Sep; 7(38):61988-61995. PubMed ID: 27542273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A curcumin derivative hydrazinobenzoylcurcumin suppresses stem-like features of glioblastoma cells by targeting Ca
    Shin HJ; Lee S; Jung HJ
    J Cell Biochem; 2019 Apr; 120(4):6741-6752. PubMed ID: 30390339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glioma-derived macrophage migration inhibitory factor (MIF) promotes mast cell recruitment in a STAT5-dependent manner.
    Põlajeva J; Bergström T; Edqvist PH; Lundequist A; Sjösten A; Nilsson G; Smits A; Bergqvist M; Pontén F; Westermark B; Pejler G; Forsberg Nilsson K; Tchougounova E
    Mol Oncol; 2014 Feb; 8(1):50-8. PubMed ID: 24091309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.